Lung Inflammation

Among patients with COPD, those receiving 6-week nicotinamide riboside, “a B3-like vitamin,” had significantly decreased lung inflammation, according to results published in Nature Aging.

Many e-cigarette and hookah smokers exhale aerosols through the nose, which may increase risk for lung inflammation and nose, sinus and throat cancers, according to findings published in Tobacco Use Insights.

IV administration of the beta-blocker metoprolol in patients with COVID-19-associated acute respiratory distress syndrome was safe and effective at reducing exacerbated lung inflammation, according to new data.

Intranasal vazegepant, a calcitonin gene-related peptide receptor agonist currently in phase 3 development for the treatment of acute migraine, will be tested as a potential treatment option for COVID-19-related pulmonary complications. Biohaven Pharmaceutical announced in a press release that the FDA has authorized initiation of a phase 2 trial of intranasal vazegepant in hospitalized patients with COVID-19 who require supplemental oxygen.

In rural areas of Nepal, use of traditional stoves that burn biomass fuel and lack proper ventilation significantly increased indoor exposure to particulate matter and carbon monoxide and were shown to induce inflammatory responses in ex vivo lung tissue, according to research published in the Annals of the American Thoracic Society.